January 31, 2014

On January 17, FDA issued its opening sally in the new compounding pharmacy enforcement regime by issuing a Warning Letter to Avella of Deer Valley in Phoenix, AZ. The letter is based on a nearly year-old inspection (February 2013) and cites the violations with respect to unapproved new drug products, misbranded drug products, and adulterated drug products.

To read the full Alert, click here.